Teva Strikes Two Settlements Over ‘Pay-For-Delay’ Agreements
Executive Summary
A California Court has secured four major settlements worth $70m with pharmaceutical companies over allegations of entering into collusive pay-for-delay agreements, including two with Teva.
You may also be interested in...
AAM Fails In Bid To Block California Pay-For-Delay Law
As the AAM failed to demonstrate a “concrete or imminent” injury to its member companies, a US appeals court has rejected the agency’s challenge to the Californian law banning “pay-for-delay” deals.
AAM Sues Over California ‘Pay-For-Delay’ Law
The AAM has filed a lawsuit seeking an injunction to prevent the implementation of Californian legislation banning ‘pay-for-delay’ deals. The law is due to come into effect in January next year.
AAM Slams California Pay-For-Delay Ban
US off-patent industry association the AAM has blasted as unconstitutional a groundbreaking California law banning so-called ‘pay-for-delay’ deals under which brand companies pay rivals to keep generics off the market.